Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly developed antibody can restore immune responses in mice. Pancreatic cancer remains ...

Fatal blood clots can arise in people who have cancer. The discovery of a cue that underlies these clots offers a therapeutic target and a way to assess clot risk. Read the paper: Extracellular ...

Protein evolution occurs slowly via small incremental mutations—usually. However, dramatic changes can happen: for instance, a fragment of one protein getting copied into the middle of another. While ...

Curadel's novel targeted zwitterionic surgical imaging drug for pancreatic cancer has been granted Orphan Drug Designation by the FDA and the EMA.